http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 23 Jun 2026 10:35:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Jun+23/26677681.html si-local-file:///var/storage/secattach/20260623/26677681.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Jun+23/26677681.html Tue, 23 Jun 2026 10:35:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Jun+23/26677681.html si-local-file:///var/storage/secattach/20260623/26677681.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Jun+23/26677681.html Tue, 23 Jun 2026 10:35:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CS+DIAGNOSTICS+CORP.++++++For%3A+Mar+31/26503074.html si-local-file:///var/storage/secattach/20260515/26503074.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CS+DIAGNOSTICS+CORP.++++++For%3A+Mar+31/26503074.html Fri, 15 May 2026 13:03:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CS+DIAGNOSTICS+CORP.++++++For%3A+Mar+31/26503074.html si-local-file:///var/storage/secattach/20260515/26503074.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-Q++++CS+DIAGNOSTICS+CORP.++++++For%3A+Mar+31/26503074.html Fri, 15 May 2026 13:03:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26318220.html si-local-file:///var/storage/secattach/20260415/26318220.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26318220.html Wed, 15 Apr 2026 15:54:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26318220.html si-local-file:///var/storage/secattach/20260415/26318220.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26318220.html Wed, 15 Apr 2026 15:54:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26244688.html si-local-file:///var/storage/secattach/20260331/26244688.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26244688.html Tue, 31 Mar 2026 06:15:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26244688.html si-local-file:///var/storage/secattach/20260331/26244688.html http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31/26244688.html Tue, 31 Mar 2026 06:15:00 -0400 CSDX O.02460067 http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html si-local-file:///var/storage/secattach/20260312/26151610.html http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html Thu, 12 Mar 2026 12:06:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html si-local-file:///var/storage/secattach/20260312/26151610.html http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html Thu, 12 Mar 2026 12:06:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html si-local-file:///var/storage/secattach/20260312/26151610.html http://www.streetinsider.com/SEC+Filings/Form++10-12GA+++CS+DIAGNOSTICS+CORP.+++++++++++++++++/26151610.html Thu, 12 Mar 2026 12:06:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Press+Releases/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html <p>CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of <strong>Shah Teelani &amp; Associates</strong>, a Dubai-based Public Company Accounting Oversight Board (PCAOB) registered audit firm, to consolidate and audit the Group 2025 financial statements.</p> <p>Under the engagement, Shah Teelani &amp; Associates will oversee the consolidation and audit of financial statements for:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>CS Diagnostics Corp. (OTCQB: CSDX)</strong></li><li style="margin-bottom:8pt;"><strong>CS Interpharm GT LLC</strong></li><li style="margin-bottom:8pt;"><strong>CS Diagnostics Pharma GmbH</strong><br/></li></ul> <p>The engagement reflects the Group’s continued commitment to strengthening financial http://www.streetinsider.com/Globe+Newswire/CS+Group+%28OTCQB%3A+CSDX%29+Appoints+Shah+Teelani+%26amp%3B+Associates%2C+a+Dubai-Based+PCAOB+Auditor%2C+to+Consolidate+All+2025+Financial+Statements+for+CSDX%2C+CS+Interpharm+GT+LLC+and+CS+Diagnostics+Pharma+GmbH/25981001.html Wed, 11 Feb 2026 10:01:00 -0400 A.15374697 CSDX O.02460067 O.20316699 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html si-local-file:///var/storage/secattach/20260204/25945923.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html si-local-file:///var/storage/secattach/20260204/25945923.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html si-local-file:///var/storage/secattach/20260204/25945923.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Diagnostics+Pharma+GmbH/25945923.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html si-local-file:///var/storage/secattach/20260204/25945924.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html si-local-file:///var/storage/secattach/20260204/25945924.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html si-local-file:///var/storage/secattach/20260204/25945924.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CS+DIAGNOSTICS+CORP.++++++For%3A+Dec+31++Filed+by%3A+CS+Interpharm+LLC/25945924.html Wed, 04 Feb 2026 14:00:00 -0400 CSDX FZRO O.02460067